ACTIVE

PHARMAPLUS INVEST

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
59,9 k €
-31,2 %over 1 year
Gross margin
274,1 k €
+1,8 %over 1 year
Equity
72,7 k €
-55,3 %over 1 year
Workforce
1,6 ETP
+6,7 %over 1 year

Identity

Source · BCE/KBO

PHARMAPLUS INVEST is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Forest. It employs on average 1,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0505.864.007
Incorporation
02/12/2014
Legal form
Private limited company
Registered office
Avenue Neptune 34
1190 Forest · BruxellesSee on map
Contributed capital
30 000,00 €
Latest accounts
31/12/2025
Average workforce
1,6 ETP
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 11 filings

Trend over 11 financial years

20252024202320222021
Income statement
Gross margin274,1 k €269,3 k €257,9 k €246,1 k €214,3 k €
EBITDA201 k €210,3 k €206,7 k €204,9 k €177,9 k €
Operating result110,6 k €149,5 k €152,9 k €152,3 k €119,8 k €
Net result59,9 k €87,1 k €93,9 k €95,7 k €71,6 k €
Balance sheet
Equity72,7 k €162,9 k €175,8 k €182 k €186,2 k €
Total assets976 k €1 M €977,1 k €987,9 k €924,9 k €
Cash528,5 k €515,2 k €467,1 k €406,5 k €324,6 k €
Debts903,3 k €840 k €801,3 k €801,3 k €737,9 k €
Other
Workforce1,6 ETP1,5 ETP1,4 ETP1,2 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

KATTY MOSZYNSKI

Manager · since 27 novembre 2014

Active

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date21/08/202620/08/202521/08/202429/06/202330/06/202230/08/2021
General meeting29/05/202630/05/202531/05/202426/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 11 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202621/08/2026FrenchPDF
Abridged model31/12/202430/05/202520/08/2025FrenchPDF
Abridged model31/12/202331/05/202421/08/2024FrenchPDF
Abridged model31/12/202226/05/202329/06/2023FrenchPDF
Abridged model31/12/202127/05/202230/06/2022FrenchPDF
Micro model31/12/202028/05/202130/08/2021FrenchPDF
Micro model31/12/201929/05/202010/11/2020FrenchPDF
Abridged model31/12/201831/05/201930/09/2019FrenchPDF
Abridged model31/12/201725/05/201828/08/2018FrenchPDF
Abridged model31/12/201626/05/201728/07/2017FrenchPDF
Abridged model31/12/201527/05/201629/08/2016FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

KATTY MOSZYNSKI

Manager · since 27 novembre 2014

Active

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office03/09/2026
    Transfert du siège social
    PDF
  • Mandates07/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring30/01/2019
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring28/11/2018
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates17/02/2015
    DEMISSIONS, NOMINATIONS
    PDF
  • Other04/12/2014
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202559,9 k €↓
  2. 2024
    Annual accounts 202487,1 k €↓
  3. 2023
    Annual accounts 202393,9 k €↓
  4. 2022
    Annual accounts 202295,7 k €↑
  5. 2022
    Name changePHARMAPLUS INVEST
  6. 2021
    Annual accounts 202171,6 k €↑
  7. 2021
    Name changePHARMACIE OSSEGHEM
  8. 2020
    Annual accounts 202050,5 k €↓
  9. 2019
    Annual accounts 201966,1 k €↓
  10. 2018
    Annual accounts 201871,9 k €↓
  11. 2017
    Annual accounts 2017101,8 k €↑
  12. 2016
    Annual accounts 201674,8 k €↑
  13. 2015
    Annual accounts 201539,5 k €
  14. 02/12/2014
    IncorporationPrivate limited company